Roger Jeffs Sells 25,000 Shares of Liquidia (NASDAQ:LQDA) Stock

Posted by Wayne Rhoads on May 14th, 2026

Liquidia Corporation (NASDAQ:LQDA – Get Free Report) CEO Roger Jeffs sold 25,000 shares of the company’s stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $41.50, for a total transaction of $1,037,500.00. Following the completion of the sale, the chief executive officer directly owned 1,298,095 shares in the company, valued at $53,870,942.50. This represents a 1.89% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Roger Jeffs also recently made the following trade(s):

On Thursday, May 7th, Roger Jeffs sold 25,000 shares of Liquidia stock. The stock was sold at an average price of $42.09, for a total transaction of $1,052,250.00.
On Tuesday, May 5th, Roger Jeffs sold 25,000 shares of Liquidia stock. The shares were sold at an average price of $40.10, for a total transaction of $1,002,500.00.
On Friday, April 17th, Roger Jeffs sold 18,839 shares of Liquidia stock. The shares were sold at an average price of $40.60, for a total transaction of $764,863.40.
On Wednesday, April 15th, Roger Jeffs sold 25,000 shares of Liquidia stock. The shares were sold at an average price of $40.14, for a total transaction of $1,003,500.00.
On Tuesday, April 14th, Roger Jeffs sold 3,300 shares of Liquidia stock. The shares were sold at an average price of $40.00, for a total transaction of $132,000.00.
On Monday, April 13th, Roger Jeffs sold 32,744 shares of Liquidia stock. The shares were sold at an average price of $38.37, for a total transaction of $1,256,387.28.
On Friday, April 10th, Roger Jeffs sold 21,433 shares of Liquidia stock. The shares were sold at an average price of $40.12, for a total transaction of $859,891.96.
On Thursday, April 9th, Roger Jeffs sold 25,000 shares of Liquidia stock. The shares were sold at an average price of $40.12, for a total transaction of $1,003,000.00.

Liquidia Stock Performance

Shares of LQDA stock opened at $57.59 on Thursday. Liquidia Corporation has a one year low of $11.85 and a one year high of $57.80. The company’s 50-day moving average is $38.70 and its 200 day moving average is $35.54. The company has a market capitalization of $5.12 billion, a price-to-earnings ratio of 411.39 and a beta of 0.41. The company has a debt-to-equity ratio of 1.18, a quick ratio of 1.84 and a current ratio of 2.22.

Liquidia (NASDAQ:LQDA – Get Free Report) last announced its quarterly earnings data on Monday, May 11th. The company reported $0.52 EPS for the quarter, beating the consensus estimate of $0.41 by $0.11. Liquidia had a net margin of 7.74% and a return on equity of 46.82%. The company had revenue of $132.87 million for the quarter, compared to the consensus estimate of $119.44 million. The firm’s revenue for the quarter was up 4187.1% compared to the same quarter last year. Sell-side analysts expect that Liquidia Corporation will post 2.14 EPS for the current fiscal year.

Hedge Funds Weigh In On Liquidia

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Covestor Ltd lifted its stake in Liquidia by 41.9% during the 4th quarter. Covestor Ltd now owns 1,216 shares of the company’s stock valued at $42,000 after acquiring an additional 359 shares during the period. PNC Financial Services Group Inc. lifted its stake in Liquidia by 7.2% during the 4th quarter. PNC Financial Services Group Inc. now owns 6,304 shares of the company’s stock valued at $217,000 after acquiring an additional 422 shares during the period. Northwestern Mutual Wealth Management Co. bought a new position in Liquidia during the 4th quarter valued at about $25,000. ProShare Advisors LLC lifted its stake in shares of Liquidia by 7.1% in the 4th quarter. ProShare Advisors LLC now owns 11,756 shares of the company’s stock worth $405,000 after purchasing an additional 775 shares during the period. Finally, Alliancebernstein L.P. lifted its stake in shares of Liquidia by 1.4% in the 3rd quarter. Alliancebernstein L.P. now owns 67,050 shares of the company’s stock worth $1,525,000 after purchasing an additional 900 shares during the period. Institutional investors own 64.54% of the company’s stock.

More Liquidia News

Here are the key news stories impacting Liquidia this week:

Positive Sentiment: Liquidia reported first-quarter results that beat expectations on both earnings and revenue, reinforcing the view that commercialization is gaining traction and that profitability is improving. Liquidia Corporation Reports First Quarter 2026 Financial Results
Positive Sentiment: Management said YUTREPIA net product sales rose 44% sequentially and projected at least $1 billion in net revenue by 2027, which signals a long growth runway if launch momentum continues. Article on YUTREPIA sales and 2027 revenue target
Positive Sentiment: Several analysts turned more constructive after the earnings report, including Needham, BTIG, and Wells Fargo, with higher price targets and buy ratings helping support the stock. Needham price target raise
Positive Sentiment: Liquidia was also added to Zacks’ Rank #1 “Strong Buy” list, adding to the bullish momentum around the shares. Zacks Strong Buy list
Neutral Sentiment: CEO Roger Jeffs and Director Stephen M. Bloch both disclosed insider stock sales, but the CEO’s sale was under a pre-arranged 10b5-1 plan and the transactions are being viewed more as monitoring points than as clear operating red flags. SEC filing
Negative Sentiment: One research note argued that YUTREPIA’s launch upside may be approaching a ceiling, suggesting some investors may worry the current growth rate becomes harder to sustain. Rating downgrade article

Wall Street Analyst Weigh In

Several brokerages recently commented on LQDA. Jefferies Financial Group reissued a “buy” rating and set a $60.00 price objective on shares of Liquidia in a research report on Monday. Zacks Research upgraded shares of Liquidia from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, May 5th. BTIG Research upped their target price on shares of Liquidia from $50.00 to $59.00 and gave the company a “buy” rating in a research note on Monday. HC Wainwright upped their target price on shares of Liquidia from $55.00 to $67.00 and gave the company a “buy” rating in a research note on Tuesday. Finally, Wall Street Zen upgraded shares of Liquidia from a “hold” rating to a “buy” rating in a research note on Saturday, March 7th. Three analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $49.33.

Check Out Our Latest Research Report on Liquidia

About Liquidia

(Get Free Report)

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).